Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Vir Biotechnology (VIR)
NASDAQ:VIR
Vir Biotechnology (VIR) Stock Price & Analysis
972 Followers
VIR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.05 - $31.78
Previous Close$26.05
Volume618.15K
Average Volume (3M)938.51K
Market Cap
$3.49B
Enterprise Value$1.37B
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$121.46M
Price to Earnings (P/E)-23.8
Beta0.62
Next Earnings
Aug 03, 2023EPS Estimate
-$1.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding133,976,538
10 Day Avg. Volume876,950
30 Day Avg. Volume938,510
Standard Deviation0.34
R-Squared0.00182
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)1.83
Price to Sales (P/S)74.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.75
Enterprise Value/Gross Profit0.95
Enterprise Value/Ebitda-4.13
Forecast
1Y Price Target
$49.00Price Target Upside88.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Vir Biotechnology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VIR FAQ
What was Vir Biotechnology’s price range in the past 12 months?
Vir Biotechnology lowest stock price was $18.05 and its highest was $31.78 in the past 12 months.
What is Vir Biotechnology’s market cap?
Currently, no data Available
When is Vir Biotechnology’s upcoming earnings report date?
Vir Biotechnology’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
How were Vir Biotechnology’s earnings last quarter?
Vir Biotechnology released its earnings results on May 04, 2023. The company reported -$1.06 earnings per share for the quarter, missing the consensus estimate of -$0.875 by -$0.185.
Is Vir Biotechnology overvalued?
According to Wall Street analysts Vir Biotechnology’s price is currently Undervalued.
Does Vir Biotechnology pay dividends?
Vir Biotechnology does not currently pay dividends.
What is Vir Biotechnology’s EPS estimate?
Vir Biotechnology’s EPS estimate is -$1.21.
How many shares outstanding does Vir Biotechnology have?
Vir Biotechnology has 133,976,530 shares outstanding.
What happened to Vir Biotechnology’s price movement after its last earnings report?
Vir Biotechnology reported an EPS of -$1.06 in its last earnings report, missing expectations of -$0.875. Following the earnings report the stock price went down -3.922%.
Which hedge fund is a major shareholder of Vir Biotechnology?
Among the largest hedge funds holding Vir Biotechnology’s share is Perceptive Advisors LLC. It holds Vir Biotechnology’s shares valued at 3M.
---
Vir Biotechnology Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$49.00 (88.10% Upside)
$49.00 (88.10% Upside)
Blogger Sentiment
Bullish
VIR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 113.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $93.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.0%
Last 30 Days ▲ 4.9%
Last 30 Days ▲ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.50%
12-Months-Change
Fundamentals
Return on Equity
-7.24%
Trailing 12-Months
Asset Growth
-7.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vir Biotechnology
Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.
---
Top 5 ETFs holding VIR
Vanguard Health Care ETF
$6.45M
iShares NASDAQ US Biotechnology UCITS ETF
$1.65M
Fidelity MSCI Health Care Index ETF
$1.01M
Fidelity Nasdaq Composite Index ETF
$809.49K
Up to five ETFs with an Outperform Smart Score that hold VIR. The ETFs are listed according to market value of VIR within the ETF
---
---